FDA approves treatment for iron overload
SILVER SPRING, Md. — The Food and Drug Adminsitration has approved a drug made by ApoPharma for a complication resulting from treatments for a genetic condition that causes anemia, the agency said Friday.
The FDA announced the approval of Ferriprox (deferiprone), used to treat patients with iron overload due to blood transfusions for thalassemia, a blood disorder. Patients with the disease have excess iron in their bodies because of the frequent blood transfusions they must receive that can lead to iron overload, a condition that can be fatal.
The standard treatment for iron overload is chelation therapy, which uses chemical agents to remove heavy metals from the body. Ferriprox, which the agency said is the first new approved treatment for the disorder since 2005, is intended for use when chelation therapy is inadequate.
Endocrine Society releases recommendations for continuous glucose monitoring
CHEVY CHASE, Md. — Patients with diabetes may benefit from a system that provides continuous, real-time glucose readings, according to new clinical practice guidelines released by the Endocrine Society.
While most patients with diabetes measure blood glucose by pricking their skin to get a drop of blood and then measuring it with a glucose meter, continuous glucose monitoring measures glucose in the interstitial fluid, the fluid between cells just under the skin.
"There are some caveats to consider before accepting continuous monitoring of glucose as a routine measure to improve glycemic control in diabetes," said David Klonoff, chairman of the task force that drafted the guidelines and a doctor at Mills-Peninsula Health Services in San Mateo, Calif. "There are still concerns about the high costs of CGM and the accuracy of the various systems available."
The new guidelines, published in the Journal of Clinical Endocrinology & Metabolism, recommend use of CGM in children and adolescents with Type 1 diabetes because it will help them maintain target blood sugar levels while reducing the risk of low blood sugar, and in adults with Type 1 diabetes who have shown they can use CGM devices on a daily basis. They also recommend refraining from using CGM alone for glucose management in hospital intensive care units and operating rooms.
Scotch-Brite introduces new botanical disinfecting wipes
ST. PAUL, Minn. — Scotch-Brite, a 3M brand, has introduced new botanical disinfecting wipes, a no-rinse household cleaning solution. The brand is encouraging families to try the wipes to disinfect their kitchen counters and prepare homemade pizzas right on the countertops in celebration of National Pizza Month.
“Disinfecting wipes are one of the fastest-growing segments in the home cleaning category,” said Heather Green, marketing manager for the Scotch-Brite brand. “That led us to bring the innovation of Scotch-Brite together with CleanWell Co., makers of the patented thyme-based disinfecting technology, to introduce a no-rinse botanical disinfecting wipe that kills 99.9% of household germs, including cold and flu viruses.”
Scotch-Brite botanical disinfecting wipes are available in lemongrass and breeze scents at a suggested retail price of $2.99 for 35 wipes and $4.99 for 75 wipes. For more information, visit Scotch-Brite.com.